Introduction
Benign myoclonic epilepsy in infancy (BMEI) is a rare syndrome first described by Dravet and Bureau 1 with about 160 patients reported in other studies on this subject. [2] [3] [4] BMEI was included among idiopathic generalized epilepsies and syndromes with agerelated onset in ILAE Classification . 5 BMEI is characterized by brief, generalized myoclonic seizures occurring, without other seizure types except rare simple febrile seizures (FS), within 3 years of age in developmentally normal children. However, some cases have a later onset up to 4 years 8 months. The ictal electroencephalogram (EEG) shows a generalized discharge of polyspikes, polyspikewaves, or spike-waves (SW). The interictal EEG is usually normal. Seizures are easily controlled by valproic acid (VPA) and disappear during childhood. Typically BMEI has good prognosis, however recent studies reported a less favourable cognitive outcome in a few cases. 2, 4, 6, 7 Long-term follow-up studies reported that a few children with BMEI after a seizure-free time interval developed other epileptic phenotypes, mainly IGE, such as rare generalized tonic-clonic seizures (GTCS), or juvenile myoclonic epilepsy (JME).
2,4,8
We report a female child with BMEI which occurred at age 11 months, followed by childhood absence epilepsy (CAE) at 6 years and 8 months old. To the best of our knowledge this occurrence has never been previously described.
Case report
The proband, a female child, was the first daughter born to healthy unrelated parents. Her family history was unremarkable with regard to neurological and psychiatric diseases except for FS of the sister and a maternal uncle. She was born at term following an uneventful pregnancy with a birth weight of 3300 kg. The postnatal course was uneventful until 11 months of age when she showed isolated myoclonic jerks involving mainly her arms and head, occurring several times a day which were misdiagnosed for five months. At 12 months she was able to walk with support, and at 17 months without support. She spoke her first word at 14 months, and at 30 months she produced two word-phrases. At age of 16 months she was referred to our Child Neuropsychiatric Department at the University of Palermo because the frequency of myoclonic jerks had increased to 20-30/die.
On admission the ictal video-EEG and polygraphic recording revealed generalized discharge of SW lasting 1-2 s associated with an isolated bilateral synchronous jerk involving mainly the upper Benign myoclonic epilepsy in infancy (BMEI) is a rare syndrome included among idiopathic generalized epilepsies (IGE) and syndromes with age-related onset. Recently, it has been shown that a few patients with BMEI later had other epilepsy types mainly IGE but never childhood absence epilepsy (CAE).
We report a patient who at 11 months of age showed isolated myoclonic jerks occurring several times a day. The ictal video-EEG and polygraphic recording revealed generalized discharge of spike-wave (SW) lasting 1-2 s associated with isolated bilateral synchronous jerk involving mainly the upper limbs controlled by valproic acid (VPA).
At 6 years and 8 months the child developed a new electroclinical feature recognized as CAE. The ictal EEG disclosed a burst of rhythmic 3 Hz generalized SW.
Our case is the first patient with BMEI reported in the literature who later developed a CAE. This finding suggests a common neurobiological and genetic link between different age-related epileptic phenotypes.
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limbs ( Fig. 1 ). Interictal EEG during wakefulness and during sleep showed age appropriate background activity. The results of blood and urine examination were within normal range.
On neurological examination, cranial nerves were unaffected, muscle tone and deep tendon reflexes were normal. In addition, the patient did not show specific minor facial or other physical anomalies.
Thus clinical and laboratory data led to BMEI diagnosis which required VPA treatment at the dose of 30 mg/kg/die. The VPA (109 g/ml) induced a seizure control within 11 days, but generalized spike-wave discharges, unrelated to clinical seizures, were still detected on EEG recordings during drowsiness at 5 years and 8 months of age. This finding suggested a long lasting antiepileptic treatment.
The psychomotor development, assessed using the The WPPSI showed a full scale IQ of 75, Verbal IQ = 80 and Performance IQ = 74. Comparison of patient scores to published norms on tests of language evaluation showed that the performances on sentence repetition, naming, morpho and phonological accuracy, and sentence structure subtests were within 5%ile (lower average range). The performances on word and sentence comprehension subtests were poor being below 5%ile.
Visualmotor integration ability was in the below average range (VMI = 84).
A new intellectual assessment at 5 years and 9 months of age showed a full scale IQ-WPPSI of 71 with a slight difference between verbal IQ (77) and performance IQ (69).
At the same session, a neuropsychological examination assessed: language (verbal fluency, naming, syntactic comprehension), verbal short term memory (digit span), verbal episodic memory (immediate and delayed word list recall, word pair learning), visual-spatial short term memory (Corsi Test), selective attention (attentional matrices) [Developmental Neuropsychological Battery, BVN 5-11, Bisiacchi 17 , and visual spatial integration ability VMI, Rey figure B copy 16 ].
The comparison of patient scores to published norms on tests of the neuropsychological battery showed an even overall profile in the lower average range. Only visual motor integration abilities were very poor (standard score 60).
In addition, the patient showed oppositional behaviour and fidgeting.
At 6 years and 8 months old the child had a new seizure type characterized by motor arrest, eye staring, abrupt and severe impairment of consciousness lasting a few seconds at frequency of 10-15 daily. The ictal EEG disclosed a burst of rhythmic 3 Hz generalized SW lasting 10-12 s (Fig. 2) and the interictal EEG during wakefulness and during sleep showed age appropriate background activity. Because the clinical and EEG findings suggested childhood absence epilepsy and the plasma level of VPA was 47 g/ml, at a lower level of the normal range, the dose of VPA was increased but it was ineffective in seizure control. Thus, ESM was started in add-on at the dose of 10 mg/kg/die and the child became seizure free.
In order to exclude associated cerebral lesions or genetic disorders in our patient we carried out a magnetic resonance imaging (MRI) study and genetic investigations.
Brain MRI at 8 years of age did not show characteristic abnormalities. Cytogenetic analysis revealed 46 XX karyotype and the array-CGH analysis did not detect genomic rearrangements.
Discussion
The electroclinical feature, the clinical course, the personal and family history of febrile seizure, the lack of chromosome rearrangements and of abnormalities on brain MRI of our patient lead us to a diagnosis of BMEI. 2 Indeed, some long-term follow-up studies have shown that seizure control was achieved in all cases, usually after a short time from treatment onset, and VPA in monotherapy was effective in more than 80% of patients with BMEI. 2, 4, 7, 8 Conversely, generalized or focal SW discharges persisted during sleep for several years after seizure control and antiepileptic treatment was long-lasting in many cases. 2, 4, 8 Furthermore, the cognitive and neuropsychological findings of our patient show an overall profile in the lower average range supporting our previous study. 7 The cognitive difficulties, ranging from very mild to severe level, were described in 15% of patients with BMEI in some studies previously published. [2] [3] [4] 6, 8 It is likely that longitudinal, wider, and formal neuropsychological assessments of all patients could detect more disabilities than those reported. The relation between cognitive outcome and the earlier seizure onset and/or the delay in the start of the treatment is not fully clear, so other unknown factors might play a role in the cognitive outcome of patients with BMEI. 2, [6] [7] [8] In addition, recent long-term follow-up studies are providing valuable information on seizure and EEG outcomes in this rare syndrome.
In a recent review, Dravet and Bureau 2 evaluated the follow-up of 79 cases (63 lasting 5 years) with BMEI reported in the literature. They found that generalized myoclonic seizures disappeared in all these cases and most patients were seizure-free within one year.
Among these patients however, 13 developed other seizure types, later in life. Rare GTCS were reported in 11/13 patients, whereas the remaining two patients, described by Prats-Viñ as et al., 9 manifested absences. One patient had a ''petit mal status'' at 10 years old, after the drug withdrawal and a free interval, the other patient had ''brief absences with marked eyelid myoclonia controlled by ESM'' at 11 years old. This data suggests that both patients might have been affected by juvenile absence epilepsy (JAE), but essential clinical information such as EEG findings were missing.
Another longitudinal study, 8 mean period of 8 years 9 months, including 22 patients, reported that 4 patients developed occasional isolated convulsive seizures that were induced by IPS or TV screens in 3 and unprovoked in one. Furthermore, a long-term follow-up of 34 new patients with BMEI 4 reported 9 patients developing seizures after the disappearance of the initial myoclonic seizures. Among them 5 patients showed FS, one had a GTCS after VPA discontinuation, 2 patients developed JME at the ages of 9 and 12 years, respectively. In another patient, cryptogenic partial epilepsy developed 12 months after a first generalized seizure at 6 years old. The later development of CAE detected in our patient provides additional data on the outcome of BMEI. Since both BMEI and CAE belong to idiopathic generalized epilepsy, the occurrence of these phenotypes in our patient likely reflects the dynamic agedependent expression of a common genetic factor rather than a casual association. 8 The age-dependent transition from an epileptic phenotype to another is being increasingly recognized in different early-onset idiopathic epilepsies such as idiopathic occipital lobe epilepsy 10 and benign familial neonatal infantile seizures 11 and likely involves pathogenetic mechanisms superimposed on physiological processes regulating normal brain development. Our study indicates the need to further investigate the relationship between the two syndromes and to elucidate the pathogenetic mechanisms of the evolution of BMEI to CAE as well as any common neurobiological and genetic substrate. The remaining Authors have no conflicts of interest.
